Cellebrite's stock surged 5.00% during intraday trading on Friday, reflecting strong investor optimism following the company's latest financial updates.

The significant price movement appears to be driven by the company's recently reported 2025 results and its 2026 guidance, which points to higher annual recurring revenue and improved profitability. Additionally, Cellebrite's strategic acquisitions in Corellium and SCG Canada, along with continued cloud adoption, have bolstered investor confidence in the company's growth trajectory.

The company's transition to a recurring, subscription-based revenue model, with over 90% of revenues now from subscriptions, is improving revenue visibility and operating leverage, factors that are likely contributing to the positive market reaction.